These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3019235)

  • 1. Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.
    Hartshorn KL; Sandstrom EG; Neumeyer D; Paradis TJ; Chou TC; Schooley RT; Hirsch MS
    Antimicrob Agents Chemother; 1986 Jul; 30(1):189-91. PubMed ID: 3019235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HTLV-III/LAV replication by foscarnet.
    Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
    Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
    Eriksson BF; Schinazi RF
    Antimicrob Agents Chemother; 1989 May; 33(5):663-9. PubMed ID: 2546487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
    Smith KO; Galloway KS; Ogilvie KK; Cheriyan UO
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1026-30. PubMed ID: 6297382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
    Schnürer J; Oberg B
    Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of therapy for infections with human T-lymphotropic virus type III.
    Hirsch MS; Kaplan JC
    Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of ribamidyl and phosphonoformic acid on the reproduction of the HTLV-III retrovirus in vitro].
    Nesterchuk SL; Gribencha SV; Barinskiĭ IF; Zhadanov VM
    Vopr Virusol; 1987; 32(3):364-6. PubMed ID: 2960081
    [No Abstract]   [Full Text] [Related]  

  • 12. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
    Frank KB; McKernan PA; Smith RA; Smee DF
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1369-74. PubMed ID: 2445282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.
    Ho DD; Hartshorn KL; Rota TR; Andrews CA; Kaplan JC; Schooley RT; Hirsch MS
    Lancet; 1985 Mar; 1(8429):602-4. PubMed ID: 2857946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
    Alenius S
    Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro effect of foscarnet on expansion of T-cells from people with LAS and AIDS.
    Beldekas JC; Levy EM; Black P; Von Krogh G; Sandstrom E
    Lancet; 1985 Nov; 2(8464):1128-9. PubMed ID: 2865599
    [No Abstract]   [Full Text] [Related]  

  • 17. Foscarnet.
    Lancet; 1985 Sep; 2(8456):648-9. PubMed ID: 2863637
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.
    Manischewitz JF; Quinnan GV; Lane HC; Wittek AE
    Antimicrob Agents Chemother; 1990 Feb; 34(2):373-5. PubMed ID: 2158278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of human herpesvirus-6 by phosphonoformate.
    Streicher HZ; Hung CL; Ablashi DV; Hellman K; Saxinger C; Fullen J; Salahuddin SZ
    J Virol Methods; 1988 Sep; 21(1-4):301-4. PubMed ID: 2972736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.